| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/07/2002 | CA2445969A1 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins |
| 11/07/2002 | CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production |
| 11/07/2002 | CA2445945A1 Modified organs and cells for xenotransplantation |
| 11/07/2002 | CA2445887A1 Haemophilus influenzae antigens |
| 11/07/2002 | CA2445847A1 A molecular marker |
| 11/07/2002 | CA2445596A1 Method for replicating the hepatitis c virus |
| 11/07/2002 | CA2445532A1 Breast cancer-associated genes and uses thereof |
| 11/07/2002 | CA2445430A1 Detection of candida |
| 11/07/2002 | CA2445423A1 Fusion genes associated with acute megakaryoblastic leukemias |
| 11/07/2002 | CA2445410A1 Ovary-specific genes and proteins |
| 11/07/2002 | CA2445338A1 G-protein coupled receptors |
| 11/07/2002 | CA2445309A1 Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| 11/07/2002 | CA2444854A1 Combinatorial libraries of monomer domains |
| 11/07/2002 | CA2444508A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 11/07/2002 | CA2444504A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 11/07/2002 | CA2443719A1 Human fibroblast growth factor-related compositions |
| 11/07/2002 | CA2441789A1 Method and kit for diagnosing gh deficiency |
| 11/07/2002 | CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 11/07/2002 | CA2439199A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants |
| 11/07/2002 | CA2415339A1 Genes and proteins for the biosynthesis of polyketides |
| 11/06/2002 | EP1255209A2 Apparatus and method for automated protein design |
| 11/06/2002 | EP1255113A1 Assay for the determination of the hormonal effect of compounds |
| 11/06/2002 | EP1254961A1 Improvments in gene therapy using compositions comprising a polynucleotide and interleukin-10 |
| 11/06/2002 | EP1254957A2 Method for producing target substance by fermentation |
| 11/06/2002 | EP1254956A2 Novel osteoinductive compositions |
| 11/06/2002 | EP1254935A2 Gelatins with good slipping properties, processes for their preparation and their uses |
| 11/06/2002 | EP1254912A1 Cyk-4 polypeptides, DNA molecules encoding them and their use in screening methods |
| 11/06/2002 | EP1254663A1 Anti-virus agent |
| 11/06/2002 | EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 11/06/2002 | EP1254269A1 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides |
| 11/06/2002 | EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 11/06/2002 | EP1254267A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 11/06/2002 | EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 11/06/2002 | EP1254263A2 Interferon-alpha induced genes |
| 11/06/2002 | EP1254260A1 Methods for diagnosing and treating heart disease |
| 11/06/2002 | EP1254256A2 Novel nucleic acids and polypeptides |
| 11/06/2002 | EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 11/06/2002 | EP1254248A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 11/06/2002 | EP1254242A1 17 human secreted proteins |
| 11/06/2002 | EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 11/06/2002 | EP1254233A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
| 11/06/2002 | EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 11/06/2002 | EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 11/06/2002 | EP1254230A2 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 11/06/2002 | EP1254227A2 Fusion receptor from tnf family |
| 11/06/2002 | EP1254226A2 Inhibitors of apoptosis |
| 11/06/2002 | EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 11/06/2002 | EP1254224A2 Interferon-alpha induced genes |
| 11/06/2002 | EP1254223A1 Cysteinyl leukotriene receptor 2 (cyslt2) |
| 11/06/2002 | EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 11/06/2002 | EP1254221A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 11/06/2002 | EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 11/06/2002 | EP1254219A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254218A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254216A2 Improved galactosylation of recombinant glycoproteins |
| 11/06/2002 | EP1254213A2 Recombinant attenuation of prrsv |
| 11/06/2002 | EP1254211A1 Cell production |
| 11/06/2002 | EP1254178A2 Synthesis of a potent paramagnetic agonist (epm-3) of the melanocyte stimulating hormone containing amino acid-type stable free radical |
| 11/06/2002 | EP1254177A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 11/06/2002 | EP1254176A2 Trade molecules and uses related thereto |
| 11/06/2002 | EP1254175A1 Human cystine knot polypeptide |
| 11/06/2002 | EP1254174A2 Human cyr61 |
| 11/06/2002 | EP1254173A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254172A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254170A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 11/06/2002 | EP1254168A2 Cytokine inhibittory molecules from tick salivary glands |
| 11/06/2002 | EP1254167A2 Preparation of deallergenized patatin proteins and patatin permutein proteins |
| 11/06/2002 | EP1254166A2 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 11/06/2002 | EP1254165A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254160A1 Par4 peptides and polypeptides |
| 11/06/2002 | EP1254157A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254156A1 Transgenic plant-based vaccines |
| 11/06/2002 | EP1254154A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254153A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254152A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254151A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254150A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254148A1 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1254147A2 Nucleic acids, proteins, and antibodies |
| 11/06/2002 | EP1253948A2 Gene therapy for treating ocular-related disorders |
| 11/06/2002 | EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 11/06/2002 | EP1253932A2 Botulinum toxin pharmaceutical compositions |
| 11/06/2002 | EP1253930A2 Method and compositions for treating hepatocellular cancer |
| 11/06/2002 | EP1253928A2 Novel haptotactic peptides |
| 11/06/2002 | EP1135518A4 Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same |
| 11/06/2002 | EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 11/06/2002 | EP1007065A4 Preparation of collagen |
| 11/06/2002 | EP0906338B1 Glucagon-like peptide-2 analogs |
| 11/06/2002 | EP0888386B1 Stable factor viii/ von willebrand factor complex |
| 11/06/2002 | EP0773959B1 Adrenergic receptor |
| 11/06/2002 | EP0757720B1 Trimerising polypeptides, their manufacture and use |
| 11/06/2002 | EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 11/06/2002 | EP0689550B1 Antimicrobial peptides from bovine neutrophils |
| 11/06/2002 | EP0635025B1 Process for preparing modified proteins |
| 11/06/2002 | EP0630264B1 Ligands for improving metal chelate formation kinetics |
| 11/06/2002 | CN1378602A Plants with modified poly unsaturated fatty acids |
| 11/06/2002 | CN1378601A Plants having altered amino acid contents and method for production thereof |
| 11/06/2002 | CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof |